Rare Disease Sleep Pilot Research Plan

罕见疾病睡眠试点研究计划

基本信息

  • 批准号:
    8381943
  • 负责人:
  • 金额:
    $ 17.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

A. Introduction: The importance of sleep to proper health has emerged in recent years. The range of sleep disorders in children is broad, although the relevance of sleep to normal development and chronic illness is not well understood. Recently, critical roles for sleep in learning, memory, neurogenesis, and neural plasticity have been described, underlying the importance of sleep to brain function and brain development1. Consistently, sleep disturbances (sleep apnea, insomnia, sleepwalking, night terrors, confusional arousals, periodic limb movements (PLMS), and bruxism) have significant adverse effects on the quality of life of children and their families. Individuals with neurological disease are at particular risk because sleep disruptions lead to exacerbation of daytime behaviors and result in poor cognitive performance2. It is important to understand the nature of sleep impairments in children with neurological disorders, since this may have important implications for the degree of impairment of quality of life and intellectual functioning. Any understanding between sleep problems and behavioral disturbances would aid such understanding. The prevalence of sleep problems in the normal population is estimated to be between 18-37% in different studies3'4. Questionnaire and interview based studies among mentally retarded subjects show that approximately 15-50% of adults and 30-67% of children have sleep problems5'6 There are very little data on sleep abnormalities in Angelman syndrome (AS), Rett syndrome (RTT), and Prader-Willi syndrome (PWS).
A.引言: 近年来,睡眠对健康的重要性开始显现。睡眠障碍的范围在 儿童是广泛的,尽管睡眠与正常发育和慢性病的相关性不是很好 明白了。最近,睡眠在学习、记忆、神经发生和神经可塑性中的关键作用 描述了睡眠对大脑功能和大脑发育的重要性。始终如一, 睡眠障碍(睡眠呼吸暂停、失眠、梦游、夜惊、昏昏欲睡、周期性肢体 运动(PLM)和磨牙症)对儿童的生活质量和他们的 家人。患有神经系统疾病的人尤其危险,因为睡眠中断会导致 白天行为恶化,导致认知能力下降2。重要的是要了解 神经系统疾病儿童睡眠障碍的性质,因为这可能有重要的意义 对于生活质量和智力功能的损害程度。睡眠与睡眠之间的任何理解 问题和行为障碍将有助于这种理解。 据估计,正常人群中的睡眠问题在不同地区的患病率在18-37%之间 研究3‘4.基于问卷和访谈的智障受试者研究表明 大约15%-50%的成年人和30%-67%的儿童有睡眠问题。 Angelman综合征(AS)、Rett综合征(RTT)和Prader-Willi综合征(PWS)的睡眠异常。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL G. GLAZE其他文献

DANIEL G. GLAZE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL G. GLAZE', 18)}}的其他基金

Rare Disease Sleep Pilot Research Plan
罕见疾病睡眠试点研究计划
  • 批准号:
    8142869
  • 财政年份:
    2010
  • 资助金额:
    $ 17.32万
  • 项目类别:
Rare Disease Sleep Pilot Research Plan
罕见疾病睡眠试点研究计划
  • 批准号:
    8153422
  • 财政年份:
    2010
  • 资助金额:
    $ 17.32万
  • 项目类别:
Rare Disease Sleep Pilot Research Plan
罕见疾病睡眠试点研究计划
  • 批准号:
    7877171
  • 财政年份:
    2009
  • 资助金额:
    $ 17.32万
  • 项目类别:
RETT SYNDROME NATURAL HISTORY CLINICAL PROTOCOL
RETT 综合征自然病史临床方案
  • 批准号:
    8166675
  • 财政年份:
    2009
  • 资助金额:
    $ 17.32万
  • 项目类别:
RETT SYNDROME NATURAL HISTORY CLINICAL PROTOCOL
RETT 综合征自然病史临床方案
  • 批准号:
    7950620
  • 财政年份:
    2008
  • 资助金额:
    $ 17.32万
  • 项目类别:
RETT SYNDROME NATURAL HISTORY CLINICAL PROTOCOL
RETT 综合征自然病史临床方案
  • 批准号:
    7605914
  • 财政年份:
    2007
  • 资助金额:
    $ 17.32万
  • 项目类别:
CLINICAL PATHOPHYSIOLOGY OF RETT SYNDROME
RETT 综合征的临床病理生理学
  • 批准号:
    7206724
  • 财政年份:
    2004
  • 资助金额:
    $ 17.32万
  • 项目类别:
PHARMACODYNAMIC EVALUATION OF THREE DIFFERENT ZOLPIDEM DOSES IN CHILDREN
三种不同唑吡坦剂量在儿童中的药效学评价
  • 批准号:
    7206762
  • 财政年份:
    2004
  • 资助金额:
    $ 17.32万
  • 项目类别:
Treatment of Rett Syndrome with Folate and Betaine
用叶酸和甜菜碱治疗 Rett 综合征
  • 批准号:
    7041646
  • 财政年份:
    2003
  • 资助金额:
    $ 17.32万
  • 项目类别:
Rett Syndrome Open Trial of Folate and Betaine
雷特综合症叶酸和甜菜碱的公开试验
  • 批准号:
    7041666
  • 财政年份:
    2003
  • 资助金额:
    $ 17.32万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 17.32万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 17.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 17.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 17.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 17.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 17.32万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 17.32万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 17.32万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 17.32万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 17.32万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了